Direct-to-patient Teledermatology and Computer-assisted Diagnosis

RECRUITING

I'm interested ...!!

This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligence system, and understand key stakeholders' attitudes regarding and readiness for remote dermatology care.

Conditions:

🦠 New Patient Use of Teledermatology Mobile App

🗓️ Study Start (Actual) 7 November 2022

🗓️ Primary Completion (Estimated) 31 December 2025

✅ Study Completion (Estimated) 30 September 2026

👥 Enrollment (Estimated) 63200

🔬 Study Type OBSERVATIONAL

📊 Phase N/A

Locations:

📍 San Francisco, California, United States

📍 Aurora, Colorado, United States

📍 Decatur, Georgia, United States

📋 Eligibility Criteria

Description

Inclusion Criteria:

* New patient referrals to dermatology at San Francisco, Decatur, and Aurora from 2021-2025

Exclusion Criteria:

* Patients who are not dermatology patients
* Dermatology patients who are not seen at San Francisco, Decatur, and Aurora
* Dermatology patients at San Francisco, Decatur, and Aurora who have visits only before 2021 or after 2025

Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)

Sexes Eligible for Study: ALL

Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

First Submitted 22 October 2021
First Submitted that Met QC Criteria 8 November 2021
First Posted 19 November 2021

Study Record Updates

Last Update Submitted that Met QC Criteria 20 March 2024
Last Update Posted 21 March 2024
Last Verified March 2024